A case of adult attention-deficit/hyperactivity disorder alleviated by milnacipran

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 3, 2007, Pages 772-775

  Kako, Yuki ^a   Niwa, Yusuke ^b   Toyomaki, Atsuhito ^a   Yamanaka, Hiroyoshi ^a   Kitagawa, Nobuki ^a   Denda, Kenzo ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kushiro City General Hospital   (Japan)

Author keywords

Adult; Anorexia nervosa; Attention deficit hyperactivity disorder; Continuous performance test; Milnacipran; Serotonin noradrenaline reuptake inhibitor

Indexed keywords

AMPHETAMINE; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; METHYLPHENIDATE; MILNACIPRAN; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; PSYCHOSTIMULANT AGENT; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ABSENCE OF SIDE EFFECTS; ADULT; ADULT DISEASE; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CYCLOPROPANES; FEMALE; FOLLOW-UP STUDIES; HUMANS;

EID: 33947491821     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.12.017     Document Type: Article

References (29)

1. Adler L.A., Resnick S., Kunz M., and Devinsky O. Open label trial of venlafaxine in adults with attention deficit hyperactivity disorder. Psychopharmacol Bull 31 (1995) 785-788
2. Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry 59 suppl 7 (1998) 4-16
3. Boonstra A.M., Kooij J.J., Oosterlaan J., Sergeant J.A., and Buitelaar J.K. Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD?. J Clin Exp Neuropsychol 27 (2005) 278-298
4. Chamberlain S.R., Muller U., Blackwell A.D., Clark L., Robbins T.W., and Sahakian B.J. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311 (2006) 861-863
5. Elliott H. Attention deficit hyperactivity disorder in adults: a guide for the primary care physician. South Med J 95 (2002) 736-742
6. Epstein J.N., Erkanli A., Conners C.K., Klaric J., Costello J.E., and Angold A. Relations between Continuous Performance Test performance measures and ADHD behaviors. J Abnorm Child Psychol 31 (2003) 543-554
7. Faraone S.V., Spencer T., Aleardi T., Pagano C., and Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 24 (2004) 24-29
8. Faraone S.V., Biederman J., Spencer T., Michelson D., Adler L., Reimherr F., et al. Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15 (2005) 664-670
9. Findling R.L., Schwartz M.A., Flannery D.J., and Manos M.J. Venlafaxine in adults with attention deficit hyperactivity disorder: an open clinical trial. J Clin J Clin Psychopharmacoly 57 (1996) 184-189
10. Hedges D., Reimherr F.W., Rogers A., Strong R., and Wender P.H. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol Bull 31 (1995) 779-783
11. Heiser P., Frey J., Smidt J., Sommerlad C., Wehmeier P.M., Hebebrand J., et al. Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. Eur Child Adolesc Psychiatry 13 (2004) 100-104
12. Kidani Y., Ishimatsu M., Kuwahata T., Yamashita Y., Akasu T., and Matsuishi T. Effects of milnacipran on neuronal excitability and synaptic transmission in neurons of the rat locus coeruleus. No To Hattatsu 37 (2005) 31-38
13. Michelson D., Adler L., Spencre T., Reimherr F.W., West S.A., Allen A.J., et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53 (2003) 112-120
14. Olvera R.L., Pliszka S.R., Luh J., and Tatum R. An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol 6 (1996) 241-250
15. O'Toole K., Abramowitz A., Morris R., and Dulcan M. Effects of methylphenidate on attention and nonverbal learning in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36 (1997) 531-538
16. Puozzo C., Panconi E., and Deprez D. Pharmacology and pharmacokinetics of milnacipran. Int Clin Psychopharmacol 17 suppl 1 (2002) S25-S35
17. Riccio C.A., and Reynolds C.R. Continuous performance tests are sensitive to ADHD in adults but lack specificity. A review and critique for differential diagnosis. Ann N Y Acad Sci 931 (2001) 113-139
18. Riccio C.A., Waldrop J.J., Reynolds C.R., and Lowe P. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13 (2001) 326-335
19. Saino H., Kurokawa Y., Kudo H., and Denda K. A case of attention deficit hyperactivity disorder with improved inattention by milnacipran. J Iwamizawa Munic Gen Hosp 30 (2004) 25-30
20. Saletu B., Grunberger J., Anderer P., Linzmayer L., Semlitsch H.V., and Magni G. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology. Br J Clin Pharmacol 33 (1992) 589-601
21. Spencer T., Biederman J., Wilens T., Prince J., Hatch M., Jones J., et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 155 (1998) 693-695
22. Spencer T., Biederman J., Wilens T., Faraone S., Prince J., Gerard K., et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58 (2001) 775-782
23. Stahl S.M., Grady M.M., Moret C., and Briley M. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10 (2005) 732-747
24. Teicher M.H., Ito Y., Glod C.A., and Barber N.I. Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psychiatry 35 (1996) 334-342
25. Wender P.H. Attention-deficit hyperactivity disorder in adults (1995), Oxford University Press, New York
26. Wilens T.E., Biederman J., Prince J., Spencer T.J., Faraone S., Warburton R., et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 153 (1996) 1147-1153
27. Wilens T.E., Spencer T.J., Biederman J., Girard K., Doyle R., Prince J., et al. A controlled clinical trial of bupropion for attention-deficit/hyperactivity disorder in adults. Am J Psychiatry 158 (2001) 282-288
28. Wender P.H., Wolf L.E., and Wasserstein J. Adults with ADHD: an overview. Ann N Y Acad Sci 931 (2001) 1-16
29. Zametkin A.J., and Rapoport J.L. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?. J Am Acad Child Adolesc Psychiatry 26 (1987) 676-686